Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases
A review in Cell Reports Medicine examines how advances in oligonucleotide chemistry and delivery have established ASOs and RNA interference therapies as a class of genetic medicines, with 21 oligonucleotides…